Revolution Medicines Inc (RVMD) average volume reaches $1.19M: Are the Stars Lining Up for Investors?

Witnessing the stock’s movement on the chart, on Wednesday, Revolution Medicines Inc (NASDAQ: RVMD) had a quiet start as it plunged -0.09% to $58.58, before settling in for the price of $58.63 at the close. Taking a more long-term approach, RVMD posted a 52-week range of $20.98-$62.40.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that the giant of the Healthcare sector posted annual sales growth of 11.11% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -36.05%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.62%. This publicly-traded company’s shares outstanding now amounts to $164.67 million, simultaneously with a float of $141.01 million. The organization now has a market capitalization sitting at $9.85 billion. At the time of writing, stock’s 50-day Moving Average stood at $51.39, while the 200-day Moving Average is $41.54.

Revolution Medicines Inc (RVMD) Ownership Facts and Figures

Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Revolution Medicines Inc’s current insider ownership accounts for 16.18%, in contrast to 88.56% institutional ownership. According to the most recent insider trade that took place on Nov 15 ’24, this organization’s General Counsel sold 2,554 shares at the rate of 55.13, making the entire transaction reach 140,811 in total value, affecting insider ownership by 43,080.

Revolution Medicines Inc (RVMD) Earnings and Revenue Records

Revolution Medicines Inc’s EPS increase for this current 12-month fiscal period is 9.62% and is forecasted to reach -4.04 in the upcoming year.

Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators

Let’s observe the current performance indicators for Revolution Medicines Inc (RVMD). It’s Quick Ratio in the last reported quarter now stands at 14.24. The Stock has managed to achieve an average true range (ATR) of 2.10. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 13316.61.

In the same vein, RVMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.59, a figure that is expected to reach -1.00 in the next quarter, and analysts are predicting that it will be -4.04 at the market close of one year from today.

Technical Analysis of Revolution Medicines Inc (RVMD)

Going through the that latest performance of [Revolution Medicines Inc, RVMD]. Its last 5-days volume of 1.02 million was inferior to the volume of 1.33 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 74.63% While, its Average True Range was 2.08.

Raw Stochastic average of Revolution Medicines Inc (RVMD) in the period of the previous 100 days is set at 82.95%, which indicates a major rise in contrast to 56.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 32.05% that was lower than 38.31% volatility it exhibited in the past 100-days period.